MENU
IBO
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Impact BioMedical (IBO) Ownership - Who owns Impact BioMedical?

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases... Show more

Profile

Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.01M
P/E Ratio
8.10
Total Cash
624K
Projected Growth
N/A
Total Debt
22.35M
Revenue
7K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.05
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

IBO
Capitalization
7.01M
P/E Ratio
8.10
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
624K
Total Cash/Share
0.05
Total Debt
22.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
7K
ROE
N/A
Book Value
-10.4M
P/B Ratio
1.84
Cash Flow
N/A
Earnings
-3.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
0.06
Current Revenue Per Employee
875.00
Dividends Per Share - Security
N/A
EBITDA
-36.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
-57.14
Revenue To Assets
-121.80
Shares Held By Institutions
382K
Shares Outstanding - Current
12.1M
Total Liabilities
26.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-60.021
View a ticker or compare two or three
IBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
275 Wiregrass Parkway
Phone
+1 585 325-3610
Employees
N/A
Web
https://www.impactbiomedinc.com